Report of Foreign Issuer (6-k)
March 14 2017 - 6:37AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM 6-K
REPORT
OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month
of March, 2017
Commission
File Number: 001-36582
Auris Medical Holding AG
(Exact
name of registrant as specified in its charter)
Bahnhofstrasse
21
6300 Zug,
Switzerland
(Address
of principal executive office)
Indicate
by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
|
|
Auris Medical Holding AG
|
|
|
|
|
|
|
|
|
|
By:
|
/s/ Anne Sabine Zoller
|
|
|
|
|
Name:
|
Anne Sabine Zoller
|
|
|
|
|
Title:
|
General Counsel
|
Date:
March 14, 2017
EXHIBIT
INDEX
Exhibit
Number
|
Description
|
99.1
|
Press Release dated March 14, 2017
|
99.2
|
Letter to Shareholders dated March 14, 2017
|
99.3
|
2016 Statutory Consolidated Financial Statements
|
99.4
|
2016 Compensation Report
|
99.5
|
2016 Statutory Standalone Financial Statements
|
Auris Medical (NASDAQ:EARS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Auris Medical (NASDAQ:EARS)
Historical Stock Chart
From Apr 2023 to Apr 2024